BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:53:00 PM | Browse: 930 | Download: 992
Publication Name World Journal of Gastroenterology
Manuscript ID 3214
Country South Korea
Received
2013-04-15 08:26
Peer-Review Started
2013-04-15 15:10
To Make the First Decision
2013-05-14 18:47
Return for Revision
2013-05-19 19:49
Revised
2013-06-05 11:44
Second Decision
2013-07-18 15:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-07-19 04:05
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-08-14 15:20
Publish the Manuscript Online
2013-08-27 16:46
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Intestinal Behçet’s disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis
Manuscript Source Invited Manuscript
All Author List Sook Hee Chung, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Tae Il Kim and Won Ho Kim
Funding Agency and Grant Number
Corresponding Author Soo Jung Park, MD, PhD, Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, 50 Yonseiro, Seodaemun-gu, Seoul 120-752, South Korea. sjpark@yuhs.ac
Key Words Intestinal Behçet’s disease; Tumor necrosis factor-α; Adalimumab
Core Tip Here, we report on a patient who was diagnosed with intestinal Beh?et’s disease despite treatment with the fully humanized tumor necrosis factor-α blocker (adalimumab) for underlying ankylosing spondylitis. This patient achieved clinical remission and complete mucosal healing through the addition of a steroid and azathioprine to the adalimumab regimen.
Publish Date 2013-08-27 16:46
Citation Chung SH, Park SJ, Hong SP, Cheon JH, Kim TI, Kim WH. Intestinal Beh?et’s disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis. World J Gastroenterol 2013; 19(32): 5389-5392
URL http://www.wjgnet.com/1007-9327/full/v19/i32/5389.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i32.5389
Full Article (PDF) WJG-19-5389.pdf
Manuscript File 3214-Review.doc
Answering Reviewers 3214-Answering reviewers.pdf
Copyright License Agreement 3214-Copyright assignment.doc
Non-Native Speakers of English Editing Certificate 3214-Language certificate.doc
Peer-review Report 3214-Peer review(s).pdf
Scientific Editor Work List 3214-Scientific editor work list.doc